tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB

Cellectar Biosciences (CLRB) Stock Investors

1,204 Followers
Based on 722,977 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLRB
On average, investors allocate 0.00% of their portfolios to CLRB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,977 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLRB

1.7%
Last 7
Days
28.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLRB, out of 722,977 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLRB Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
3.87%
$2.83
Based on the activity of 13,601 investors who made their portfolios public
The table shows changes in CLRB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLRB Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
+0.86%
+1.66%
40.91B
Consumer Cyclical
ChargePoint Holdings
3.95%
-1.04%
-3.27%
727.37M
Consumer Cyclical
Coherus Biosciences
2.69%
-0.54%
-3.68%
259.48M
Healthcare
Riot Platforms
4.98%
+0.99%
+6.18%
2.89B
Financial
Marathon Digital Holdings
5.70%
-0.56%
+7.09%
5.90B
Financial
Assertio Therapeutics
2.70%
-1.15%
-4.74%
98.80M
Healthcare
Plug Power
4.91%
-0.83%
+0.65%
2.33B
Industrials
Blink Charging Co
5.05%
-0.46%
+4.05%
241.37M
Industrials
Li Auto
5.54%
+0.23%
+5.77%
30.57B
Consumer Cyclical
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Based on the activity of 722,977 active portfolios
Open your Smart Portfolio

CLRB Investor Analysis

CLRB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.9%
of CLRB holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
CLRB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.1%
of CLRB holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
CLRB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
34.0%
of CLRB holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of CLRB stock investors
See who invests in CLRB according to age group and performance.

FAQ

How many retail Investors hold CLRB?
<0.1% of TipRanks' retail investors hold CLRB in their portfolios.
    What is CLRB Investor Sentiment?
    CLRB’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CLRB in the last 7 days?
      ▲ 1.7% of TipRanks' retail investors changed their holding of CLRB in the last 7 days.
        What percentage of retail investors changed their holding of CLRB in the last 30 days?
        ▲ 28.6% of TipRanks' retail investors changed their holding of CLRB in the last 30 days.
          What is the average age of retail investors who hold CLRB?
          The average age of CLRB Holders is between 35–55.
            What other stocks have CLRB investors also bought?
            CLRB Investors also bought DKNG, CHPT, CHRS, RIOT, MARA, ASRT, PLUG, BLNK, LI, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis